This trial is testing whether a treatment for knee cartilage defects is safe and effective.
2 Primary · 13 Secondary · Reporting Duration: Week 0 (pre-operation), and up to 24 Months (post-operation)
Active Control
Experimental Treatment
25 Total Participants · 2 Treatment Groups
Primary Treatment: Autologous Chondrocyte Implantation (CartiLife®) · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: